Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.740
-0.020 (-0.72%)
At close: Mar 9, 2026, 4:00 PM EDT
2.750
+0.010 (0.36%)
After-hours: Mar 9, 2026, 4:04 PM EDT
Cellectar Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 13.2 | 23.29 | 9.56 | 19.87 | 35.7 | |
| Cash & Short-Term Investments | 13.2 | 23.29 | 9.56 | 19.87 | 35.7 | |
| Cash Growth | -43.34% | 143.48% | -51.85% | -44.36% | -37.54% | |
| Prepaid Expenses | 0.84 | 0.96 | 0.89 | 0.66 | 0.87 | |
| Total Current Assets | 14.04 | 24.25 | 10.45 | 20.53 | 36.57 | |
| Property, Plant & Equipment | 0.91 | 1.19 | 1.59 | 0.98 | 0.55 | |
| Other Long-Term Assets | 0.03 | 0.03 | 0.03 | 0.08 | 0.08 | |
| Accounts Payable | 1.44 | 4.11 | 9.18 | 2.56 | 1.41 | |
| Accrued Expenses | 2.48 | 2.17 | - | 2.91 | 2.44 | |
| Current Portion of Leases | 0.1 | 0.08 | 0.06 | 0.05 | 0.14 | |
| Other Current Liabilities | 0.73 | 3.03 | 16.12 | 5.98 | - | |
| Total Current Liabilities | 4.75 | 9.39 | 25.36 | 11.5 | 3.99 | |
| Long-Term Leases | 0.31 | 0.41 | 0.49 | 0.55 | 0.17 | |
| Common Stock | 0 | 0 | 0 | 0 | 0 | |
| Additional Paid-In Capital | 277.15 | 261.12 | 182.92 | 168.14 | 182.56 | |
| Retained Earnings | -269.13 | -247.34 | -202.76 | -159.99 | -150.9 | |
| Total Common Equity | 8.02 | 13.77 | -19.84 | 8.15 | 31.66 | |
| Total Liabilities & Equity | 14.98 | 25.47 | 12.08 | 21.59 | 37.2 | |
| Total Debt | 0.41 | 0.49 | 0.55 | 0.6 | 0.3 | |
| Net Cash (Debt) | 12.79 | 22.79 | 9.01 | 19.26 | 35.4 | |
| Net Cash Growth | -43.91% | 152.94% | -53.22% | -45.59% | -37.61% | |
| Net Cash Per Share | 4.90 | 18.41 | 22.12 | 81.90 | 191.31 | |
| Filing Date Shares Outstanding | 4.24 | 1.54 | 1.08 | 0.32 | 0.2 | |
| Total Common Shares Outstanding | 4.24 | 1.54 | 0.69 | 0.31 | 0.2 | |
| Working Capital | 9.29 | 14.86 | -14.91 | 9.03 | 32.58 | |
| Book Value Per Share | 1.89 | 8.97 | -28.69 | 26.06 | 155.46 | |
| Tangible Book Value | 8.02 | 13.77 | -19.84 | 8.15 | 31.66 | |
| Tangible Book Value Per Share | 1.89 | 8.97 | -28.69 | 26.06 | 155.46 | |
| Machinery | - | - | - | 0.8 | 0.58 | |
| Leasehold Improvements | - | - | - | 0.31 | 0.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.